Gregory I Ostrow

This inventor holds 20 USPTO granted patents and 18 published patent applications, plus 1 CIPO patent and 3 EPO patents, primarily in Ophthalmic Formulations. Top assignee: Sydnexis, Inc.. Active years: 2016-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Gregory I Ostrow. Retrieved from https://idiyas.com/inventor/gregory-i-ostrow

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 20 (Patent Applications = 18)

% Patents Active = 100.0

CIPO Patents = 1 (Patent Applications = 2)

EPO Patents = 3 (Patent Applications = 5)

Average Co-Inventor Count = 3.2

ph-index = 9

Forward Citations = 196(Granted Patents)

Company Filing History:

20 out of 20

Sydnexis, Inc.

patents

Years Active: 2016-2026

Loading Chart...

Areas of Expertise:

Ophthalmic Composition

Pharmaceutical Formulations

Stabilized Formulations

D2O Stabilization

DO Stabilization

Eye Care Products

Drug Delivery

Topical Solutions

Therapeutic Agents

Biocompatible Materials

Liquid Formulations

Active Ingredients

20 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12629360 - Ophthalmic composition (2026-05-19),

2. 12168017 - DO stabilized pharmaceutical formulations (2024-12-17),

3. 12070466 - DO stabilized pharmaceutical formulations (2024-08-27),

4. 11896588 - Ophthalmic composition (2024-02-13),

5. 11890277 - Ophthalmic composition (2024-02-06),

6. 11883390 - Ophthalmic composition (2024-01-30),

7. 11596625 - Ophthalmic composition (2023-03-07),

8. 11382909 - Ophthalmic composition (2022-07-12),

9. 11052095 - D2O stabilized pharmaceutical formulations (2021-07-06),

10. 11052094 - Do stabilized pharmaceutical formulations (2021-07-06),

11. 10953002 - Ophthalmic composition (2021-03-23),

12. 10940145 - Ophthalmic composition (2021-03-09),

13. 10888557 - Ophthalmic composition (2021-01-12),

14. 10864208 - Ophthalmic composition (2020-12-15),

15. 10842787 - Ophthalmic composition (2020-11-24),

Title: The Innovation Journey of Gregory I Ostrow: Pioneering Ophthalmic Formulations

Introduction:

Gregory I Ostrow, a brilliant inventor based in San Diego, CA, is renowned for his groundbreaking work in ophthalmic formulations. With an impressive portfolio of 18 patents, Ostrow has significantly contributed to the advancement of eye care and treatment methodologies.

Latest Patents:

Ostrow's latest patents showcase his expertise in developing innovative ophthalmic compositions. His patent on DO stabilized pharmaceutical formulations, utilizing deuterated water, offers a novel approach to treating ophthalmic conditions. Additionally, his work on ophthalmic compositions with low concentrations of agents and deuterated water demonstrates a unique method for addressing myopia development.

Career Highlights:

Currently affiliated with Sydnexis, Inc., a leading company in the healthcare industry, Ostrow continues to push the boundaries of ophthalmic research and development. His dedication to improving eye health has led to the successful implementation of his patented formulations in clinical settings, benefiting countless individuals worldwide.

Collaborations:

Throughout his career, Ostrow has collaborated closely with esteemed colleagues such as Kenneth J Widder and David S Baker. Together, they have promoted a culture of innovation and excellence, driving forward the field of ophthalmology with their collective expertise and shared vision.

Conclusion:

Gregory I Ostrow's unwavering commitment to innovation and his remarkable contributions to ophthalmic science underscore his status as a pioneering inventor in the healthcare sector. His inventive spirit and collaborative approach continue to inspire advancements in eye care, positioning him as a key figure in the realm of innovative ophthalmic formulations.

Profile summary based on public USPTO records.